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A report on the third annual joint meeting of the British
Society for Proteome Research and the European
Bioinformatics Institute, Hinxton, UK, 12-14 July 2006.
A recent meeting at the European Bioinformatics Institute
outside Cambridge, UK, focused on the need to integrate
current proteomics methods with advances in both mass.
spectrometric (MS) technology and bioinformatics software.
The increasing sensitivity of MS coupled with enhanced
separation techniques mean that the quantity and quality of
the data produced from high-throughput studies are
increasing continuously. Without bioinformatics techniques
to analyze these data comprehensively, the benefits of the
more sensitive technology would be lost. Here, we report
some of the highlights of the meeting.
With the emergence of systems biology, entire organisms,
organs and tissues are now being characterized. The routine
identification of abundant individual proteins from a wide
variety of organisms has been possible for decades, but until
recently the analysis of less abundant components of the
proteome has been somewhat restricted by the methods
available. In her plenary lecture, Peipei Ping (University of
California, Los Angeles, USA) described a strategy for the
isolation, identification and validation of purified organelles
from heart tissue, using sophisticated separation techniques
before MS analysis to enable the identification of less
abundant cardiac proteins. Typically, after glycerol gradient
purification, strong cation-exchange chromatography was
used, coupled with tandem MS (MS/MS) of digests for protein
identification. Native gel electrophoresis was subsequently
used for the functional validation of the identified proteins. It
was clear from her studies that it is extremely important to
perform manual validation of mass spectrometric data and to
consider complementary data from alternative techniques, in
order to establish confidence in protein identifications.
The importance of quantification
To help understand how an organism works as a whole, it is
important to quantify proteins accurately following their
identification. Rob Beynon (University of Liverpool, UK)
stressed the need for both relative and absolute quantitative
proteomics. He reported a novel methodology (QconCAT
[http://www.entelechon.com/index.php?id=qcats/index])
for absolute quantification of proteins that is able to
simultaneously quantify a number of different proteins
within a complex proteome. QconCATs are synthetic
proteins that are designed to encode internal standards for a
number of different proteins. The protein is expressed
(typically in heavy-isotope-labeled form), purified,
quantified, and added as an internal standard to the
biological sample of interest before chemical or proteolytic
cleavage. Alternatively, absolute quantification is enabled by
the chemical synthesis, quantification and introduction of
individual internal standards. QconCATs enable
standardization of the quantity of internal standards and the
production of internal standards on a larger scale, thus
increasing the throughput of absolute protein quantification.
Kathryn Lilley (University of Cambridge, UK) summarized
some of the methods currently used for relative quantifi-
cation in proteomics, specifically differential gel electro-
phoresis (DIGE), isotope-coded affinity tags (ICAT), isobaric
tagging for relative and absolute quantification (iTRAQ) and
label-free MS techniques, and discussed the importance of
identifying the advantages of each in order to use it to its full
potential. DIGE is a well established technique and allows
the visualization of different isoforms. However, the
technique is not optimal for membrane proteins, allowing
the analysis of only a limited number of species. Stable-
isotope-labeling techniques such as ICAT and iTRAQ allow
good proteome coverage and multiplexing of a number of
samples although they can be somewhat costly and are
reliant on a stable chromatographic gradient. Lilley
emphasized that assessments of the technical and biologicalvariance of the techniques and samples under investigation
are equally important when quantifying proteins within
complex samples. Biological variation can be compensated
for by the use of matched controls and technical variation
can be minimized by combining biological samples and
internal standards as early as possible in the procedure.
With the use of technical replication, both biological and
technical variance can be overcome.
A number of studies were also presented on the relative
quantification of proteins using protein microarrays. Cris
dos Remedios (Institute for Biomedical Research,
University of Sydney, Australia) presented an antibody
array technique that could reportedly identify a variety of
diseases, primarily ischemic heart disease, using
biomarker-specific antibodies. Jennifer van Eyk (Johns
Hopkins University, Baltimore, USA) reported work on
biomarker discovery for myocardial ischemia using two-
dimensional gel electrophoresis followed by LC-MS/MS for
protein identification. iTRAQ was used for relative
quantification of the proteins, and the identifications were
confirmed by immunoassays. The traditional cellular
necrosis markers cardiac troponin I and troponin T were
monitored in myocardial ischemia in human patients.
Detecting post-translational modifications
Post-translational modification of proteins plays an impor-
tant role in regulating numerous cellular processes, and a
major focus of discussion at the meeting was the effect of
glycosylation in relation to the progression of disease. Ros
Banks (University of Leeds, UK) has identified novel
protein biomarkers for ovarian cancer using DIGE followed
by lectin-based two-dimensional profiling to analyze both
serum proteins and glycoproteins. The lectin-based
profiling allows the selection of glycoproteins by capture of
the glycan side chain. Biomarkers are required most
urgently in cancer, where disease progression can be rapid
and the disease is often undiagnosed until the stage of
metastasis. Noninvasive diagnosis is the main aim of
current studies to identify proteins that are altered in
metastatic cancer and thus could be used as biomarkers for
the development of metastasis.
It has been known for some years that glycosylation of
proteins has a profound effect upon metastasis in human
cancer. Pauline Rudd (University of Oxford, UK) reported the
identification of glycosylated protein biomarkers that were
either up- or downregulated in ovarian cancer; of particular
interest was the finding that atamin, an existing biomarker for
infertility, was downregulated in ovarian cancer. Overall, it
was clear that better techniques are needed for the high-
throughput analysis of glycoproteins in biological samples. In
the area of phospho-proteomics, technical developments in
commercial MS technology that should help in the analysis of
post-translational modifications were described. The use of
electron transfer dissociation (ETD) for this purpose was
discussed by Marcus Macht (Bruker Daltonics, Coventry, UK).
This method of ion activation cleaves the peptide at the N-Cα
bond and leaves post-translational modifications intact,
thereby permitting identification of the exact location of the
modification.
Identifying lower-abundance proteins
Improved ion-fragmentation techniques coupled with the
increased sensitivity of state-of-the-art mass spectrometers
have facilitated the identification of lower-abundance
proteins as well as aiding the characterization of post-
translational modifications. One of us (SJG) described one
way of helping to ensure that high-lysine low-abundance
proteins are detected - by increasing peptide detection using
guanidination. It had been previously shown that when
analyzing peptides by matrix-assisted laser desorption
ionization (MALDI) MS, arginine-terminating tryptic peptides
are better detected. To overcome this bias, our group has
used guanidination to convert lysine to homoarginine to
facilitate increased detection of lysine-terminated peptides
by MALDI MS. When using MS/MS, an improved signal-to-
noise ratio is commonly observed, and fragment ions can be
used for both identification and quantification of low-
abundance proteins, in the latter case using stable-isotope-
labeled internal standards.
Beynon introduced an amino-terminal peptide-enrichment
strategy that addresses the difficulties in identifying low-
abundance proteins. Complex biological samples are proteo-
lytically digested and the amino-terminal peptide of each
protein is selectively isolated, thereby decreasing the
complexity of the peptide mixture. Subsequent database
searching for protein recognition benefits from the
knowledge of the position of the proteolytic peptide analyzed.
A relatively new development in proteomics is the use of
mass spectrometry for imaging. Graham Cooks (Purdue
University, West Lafayette, USA) spoke eloquently about
his work on desorption electrospray ionization (DESI), a
mass spectrometric technique that allows the imaging and
the ambient mass spectrometric analysis of tissue samples
without extensive preparation. Cooks envisages the further
development of DESI for the analysis of living tissue
samples in biomedical science. This technology typifies the
need for the development of mass spectrometric techniques
for a much wider range of applications than are currently
commercially available. Along related lines, Richard
Caprioli (Vanderbilt University School of Medicine,
Nashville, USA) has used MALDI MS for in situ molecular
profiling and imaging of proteins in isolated tissues. The
use of MALDI as an imaging technique that can be used in
conjunction with the analysis of proteins and small
molecules in tissues is particularly important for defining
the location of specific drugs, lipids, peptides, and proteins
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great potential for the further development of MS for
proteomics and beyond.
Software for proteomics
It is clear that powerful bioinformatics tools are needed to
allow us to benefit from the improvements in separation and
analytical techniques, especially in high-throughput
analysis, a point emphasized throughout the meeting. One
pressing need is for powerful publicly available proteomics
software. Both Jimmy Eng (Fred Hutchinson Cancer
Research Center, Seattle, USA) and Ronald Beavis
(University of British Columbia, Vancouver, Canada)
presented their work on open-source software that facilitates
protein identification, validation, quantification and data
storage (available at CPAS website [http://cpas.fhcrc.org]
and the Global Proteome Machine Organization website
[www.thegpm.org], respectively). Conrad Bessant (Cranfield
University, Cranfield, UK) addressed the data-processing
bottleneck in proteomics with the genome-annotating
proteomic pipeline (GAPP; available at the GAPP website
[http://www.gapp.info]).
This year’s joint BSPR/EBI meeting successfully brought
together new developments in mass spectrometric technology
and bioinformatics to the wider field of proteomics. To gain
a fuller understanding of the function and interaction of
proteins within a proteome it will be important to optimize
the use of MS and bioinformatics techniques to facilitate
proteomic  characterization. The development of analytical
techniques for protein identification and subsequent absolute
quantification in cell lysates will be extremely important in
increasing proteome coverage and enabling a systems-
biology approach to analyzing the function of proteins within
the whole organism. Software and tools will be needed to
facilitate the distribution of existing and future data, and also
to increase the power of data analysis to keep up with
developments in separation technology of biological samples.
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